1. Home
  2. VYNE vs MLSS Comparison

VYNE vs MLSS Comparison

Compare VYNE & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.61

Market Cap

20.4M

Sector

Health Care

ML Signal

HOLD

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.28

Market Cap

22.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYNE
MLSS
Founded
2003
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
22.1M
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
VYNE
MLSS
Price
$0.61
$0.28
Analyst Decision
Hold
Buy
Analyst Count
1
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
138.7K
996.3K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
N/A
$8,973,982.00
Revenue This Year
N/A
$12.64
Revenue Next Year
N/A
$8.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.99
52 Week Low
$0.29
$0.22
52 Week High
$1.98
$1.11

Technical Indicators

Market Signals
Indicator
VYNE
MLSS
Relative Strength Index (RSI) 52.85 47.90
Support Level $0.56 $0.27
Resistance Level $0.75 $0.30
Average True Range (ATR) 0.02 0.02
MACD 0.00 -0.00
Stochastic Oscillator 68.54 38.04

Price Performance

Historical Comparison
VYNE
MLSS

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

Share on Social Networks: